美股周四早盘生物制药公司Invivyd(IVVD)股价重挫18%%此前该公司宣布通过证券发行筹集5000万美元资金。这笔融资将用于支持临床项目包括针对长新冠的单克隆抗体疗法研究。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.